Literature DB >> 17971192

Outcome of childhood ulcerative colitis at 2 years.

L J Howarth1, A E Wiskin, D M Griffiths, N A Afzal, R M Beattie.   

Abstract

AIM: Ulcerative Colitis (UC) has an incidence of 1.4 per 100,000 in childhood. There is a paucity of data regarding outcome particularly with the increased use of early immunosuppression. This study reviews outcome at 2 years in a cohort with UC referred to a single centre.
METHOD: Patients were recruited on the basis of a diagnosis made between 2000 and 2003 as a consecutive cohort. All had UC according to standard clinicopathological criteria. Children with indeterminate colitis were excluded. Follow-up data was collected at 2 years by case notes review.
RESULTS: Thirty-two children are reported. The median age at diagnosis was 11 years (range 2-16). All were treated with corticosteroids and 5-ASA derivatives at diagnosis. The majority of patients (94%, 30/32) received more than one course of steroids. By 2 years azathioprine use was high with 75% (24/32) of patients on treatment for steroid-dependent disease. There were 6 extra-intestinal manifestations and 8 disease related complications occurring in 12 patients (38%). The colectomy rate was 9% (3/32) for unresponsive disease.
CONCLUSION: There is a high need for Azathioprine in childhood UC. Colectomy rate at 2 years was around 10%. Extra-intestinal manifestations and disease related complications are common.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17971192     DOI: 10.1111/j.1651-2227.2007.00515.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  1 in total

1.  Anemia Screening, Prevalence, and Treatment in Pediatric Inflammatory Bowel Disease in the United States, 2010-2014.

Authors:  Steven D Miller; Carmelo Cuffari; Eboselume Akhuemonkhan; Anthony L Guerrerio; Harold Lehmann; Susan Hutfless
Journal:  Pediatr Gastroenterol Hepatol Nutr       Date:  2019-02-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.